Contract 75A50122C00047
Emergent Biodefense Operations Lansing Llc · Department Of Health And Human Services · September 19, 2024
Emergent Biodefense Operations Lansing Llc was awarded a federal contract by Department Of Health And Human Services (Office Of Assistant Secretary For Preparedness And Response) on September 19, 2024 for $84.50 million of work in research and development in biotechnology (except nanobiotechnology). Performance is in Durham, NC. It was awarded under full and open competition. The contract has been modified 1 time since the base award It uses firm fixed-price contract pricing. The most recent modification was on September 5, 2025. If all options are exercised, the contract could reach $647.49 million.
Contract details
- PIID
- 75A50122C00047
- Award type
- Definitive Contract
- Pricing
- Firm Fixed Price
- Set-aside
- No Set Aside Used.
- Competition
- Not Competed
- NAICS
- 541714 · Research And Development In Biotechnology (Except Nanobiotechnology)
- Product / service
- General Science & Technology R&D Svcs; General Science & Technology; R&D Facilities & Maj Equip
- Place of performance
- Durham, NC
- First action
- September 19, 2024
- Latest action
- September 5, 2025
Description
THE PURPOSE OF THIS MODIFICATION IS TO EXERCISE CLIN0004B IN THE AMOUNT OF $17,104,200 FOR 40,000 TREATMENT COURSES OF ORAL SUSPENSION TEMBEXA AND UPDATED ARTICLE B.2.2 OPTIONS, TABLE 5.
Modification timeline
-
September 5, 2025Mod P00007 · Exercise An Option$211.41M
-
September 19, 2024Mod P00005 · Exercise An OptionCHIMERIX INC: AR&D FOR SMALLPOX ANTIVIRAL$211.41M
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Vericel Corporation | Department Of Health And Human Services | April 1, 2026 | $34.88M |
| American College Of Medical Toxicology, Inc. | Department Of Health And Human Services | March 31, 2026 | $0 |
| Ceramedix Holding, Llc | Department Of Health And Human Services | March 31, 2026 | $4.22M |
| Glaxosmithkline, Llc | Department Of Health And Human Services | March 31, 2026 | $7.79M |
| Care Access Research Llc | Department Of Health And Human Services | March 31, 2026 | $2.55M |
| Pattern Bioscience, Inc. | Department Of Health And Human Services | March 31, 2026 | $22.50M |
Top contractors in NAICS 541714
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Amgen USA Inc | 1 | $59.99M |
| 2 | Vericel Corporation | 1 | $34.88M |
| 3 | Spectral Md, Inc. | 1 | $31.67M |
| 4 | Ppd Development Lp | 6 | $31.12M |
| 5 | L3 Technologies, Inc. | 1 | $22.00M |
| 6 | Technical Resources International, Inc. | 6 | $21.80M |
| 7 | Abbott Laboratories | 1 | $21.01M |
| 8 | Paratek Pharmaceuticals, Inc | 1 | $17.47M |
| 9 | Ossium Health, Inc. | 1 | $12.39M |
| 10 | Rho Federal Systems Division Inc | 1 | $8.00M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75A50122C00047?
Contract 75A50122C00047 is a federal contract awarded to Emergent Biodefense Operations Lansing Llc by Department Of Health And Human Services on September 19, 2024 for $84.50 million of work classified under RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY). It has been modified 1 time since the base award.
Who won contract 75A50122C00047?
Emergent Biodefense Operations Lansing Llc won contract 75A50122C00047 from Department Of Health And Human Services.
How much is contract 75A50122C00047 worth?
Contract 75A50122C00047 has obligated $84.50 million to date, with a total potential value of $647.49 million if all options are exercised.